Previous Article | Next Article 
Infection and Immunity, December 2005, p. 8449-8452, Vol. 73, No. 12
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.12.8449-8452.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Different Helicobacter hepaticus Strains with Variable Genomic Content Induce Various Degrees of Hepatitis
Samuel R. Boutin,1,2
Zeli Shen,1
Arlin B. Rogers,1
Yan Feng,1
Zhongming Ge,1
Sandy Xu,1
Torsten Sterzenbach,3
Christine Josenhans,3
David B. Schauer,1,2
Sebastian Suerbaum,3 and
James G. Fox1,2*
Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts,1
Division of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts,2
Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany3
Received 11 July 2005/
Accepted 15 September 2005

ABSTRACT
A 70-kb genomic island (HHGI1) in
Helicobacter hepaticus strain
ATCC 51449 is a putative pathogenicity island (PAI). To determine
the in vivo relevance of this PAI, we inoculated A/JCr mice
with one of three strains of
H. hepaticus: type strain Hh3B1,
which contains the complete PAI, and strains HhNET and HhG,
which lack all or large parts of HHGI1, respectively. Mice infected
with HhG and HhNET developed less-severe hepatitis than male
A/JCr mice infected with Hh3B1.

TEXT
Helicobacter hepaticus causes chronic hepatitis and hepatocellular
carcinoma in A/JCr mice (
3,
4,
11) and typhlocolitis in susceptible
mouse species, as well as lower-bowel cancer in 129S6 Rag 2
/ mice (129SG/SvEvTac-Rag2
tm1Fwa) (
1,
2,
7). Genome sequence analysis
of
H. hepaticus revealed the presence of a genomic island with
low G+C content that comprises 70 kb of sequence and 71 predicted
genes. The island, in part, comprises elements that suggest
a role of the island in virulence. This island, termed
H. hepaticus genomic island 1 (HHGI1), comprises three genes that encode
homologs of components (VirB10, VirB4, and VirD4) of a type
IV secretion system (T4SS). HHGI1 also contains a gene with
homology to
Vibrio cholerae hcp, which encodes a secreted protein
coregulated with the
V. cholerae hemolysin, a gene cluster (HH244
to HH251) with significant homology to clusters of genes of
unknown function on the small chromosome of
V. cholerae (VCA0107
to VCA0115) and the
Yersinia pestis genome. Unlike many pathogenicity
islands, HHGI1 is not associated with a tRNA gene and not flanked
by direct repeats. However, it contains a prophage P4-like integrase
gene (HH0269), a feature that has been found in several pathogenicity
islands. In the same study, we established by genome comparisons
with a whole-genome DNA microarray that while all strains that
had been associated with liver disease, including the sequenced
strain 3B1 (ATCC 51449), contained the complete island, many
H. hepaticus isolates lack parts of the island or even all HHGI1
genes. Significantly, none of these HHGI1-defective strains
had caused liver disease in the mice from which they had been
isolated. Taken together, these data suggested that HHGI1 might
be involved in virulence of
H. hepaticus. We addressed whether
H. hepaticus isolates differ in their potential to induce liver
disease, in order to obtain more evidence for a potential role
of the HHGI1 island in
H. hepaticus virulence. We therefore
selected two
H. hepaticus isolates, HhNET and HhG, with partial
or complete deletions of the island and compared their virulence
with that of the sequenced strain that harbors the complete
island. Hybridizations with a whole-genome microarray indicated
that in comparison to the sequenced strain 3B1, HhNET lacked
229 genes and HhG lacked 173 genes. Notably, microarray experiments
and extensive confirmatory PCRs showed that HhNET does not have
any genes of the HHGI1 island (HH234 to HH302), and HhG lacks

62 out of 70 kb of the island, including all three type IV secretion
system components (
10).
Specific-pathogen-free male (n = 34) and female (n = 30) A/JCr mice that were viral antibody free, free of pathogenic bacteria and parasites, and Helicobacter free were purchased from the National Cancer Institute and maintained in an AAALAC animal facility. Mice were euthanized by CO2 asphyxiation at 3 months p.i. (one mouse from each cage; a total of eight males and eight females) and 6 months p.i. (controls, seven males, four females; Hh3B1, six males, six females; HhG, six males, six females; HhNET, seven males, six females).
H. hepaticus strains ATCC 51449 (Hh3B1), MIT 96-284 (HhG), and MIT 96-1809 (HhNET) were utilized in this experiment. Hh3B1 is an HHGI1 island-containing strain which was used to determine the H. hepaticus genome sequence (10). MIT 96-284 (HhG) and MIT 86-1809 (HhNET) were isolated at Massachusetts Institute of Technology from mice obtained from mouse colonies in Germany and The Netherlands, respectively. The genome contents of these two strains have been compared to that of the sequenced strain 3B1 by whole-genome microarray hybridization and confirmatory PCRs (10). The identities of strains were verified before inoculation and after necropsy by PCRs with primer pairs targeting the genes Hh0082 (present in Hh3B1 and HhNET; forward, 5'-GGAGCTTCCTCTTGTATGCC-3'; reverse, 5'-TACAACCCTGCATTTTGCACC-3'), Hh0236 (present only in Hh3B1; forward, 5'-ATCACTTAGATTGACATAGAGC-3'; reverse, 5'-ATAATCCAAACAATGCAACTCG-3'), and Hh0298 (present in 3B1 and HhG; forward, 5'-GTGTTTGATTAACTCCTATCCC-3'; reverse, 5'AAAGAACGGATAACTCATCGC-3').
H. hepaticus strains were cultured and mice dosed per os as described previously (3, 4). At 10 weeks of age, mice (Hh3B1, eight males and eight females; HhG, eight males and eight females; HhNET, nine males and eight females) received 0.2 ml of fresh H. hepaticus inoculum, per dose, by oral gavage on three different days over a 2-week time period. Controls consisting of nine males and six females received phosphate-buffered saline. Pooled fecal samples from all cages representative of all the experimental groups were cultured for H. hepaticus (9). DNA was extracted from the cecal contents using QIAGEN DNA Stool Mini kit no. 51504 (QIAGEN, Valencia, CA), and DNA was extracted from paraffin-embedded cecal samples using the EX-WAX DNA extraction kit (Chemicon International, Temecula, CA) per the manufacturer's instructions. The H. hepaticus presence in the liver for all 48 mice was assessed by real-time quantitative PCR using the PE Applied Biosystems sequence detection system (model 7700; Applied Biosystems, Foster City, CA) as described previously (5).
Sagittal sections of each liver lobe were collected for histopathology. Tissues were immersion fixed overnight in 10% neutrally buffered formalin, processed, embedded, sectioned at 5 µm, and stained with hematoxylin and eosin. Lesion scores were assigned by a comparative pathologist blinded to sample identity on a 0-to-4 scale for lobular and portal histologic activity as defined elsewhere (6, 8). A histologic activity index (HAI) was composed by combining lobular and portal hepatitis grades. Analyses of H. hepaticus liver colonization and hepatitis scores of all H. hepaticus-infected A/JCr mouse groups and controls were performed by using the Kruskal-Wallis test with Dunn's multiple comparison posttest.
Each of the three strains of H. hepaticus was cultured from feces of two mice each from cages housing H. hepaticus-infected mice at 12 weeks postinfection (p.i.), but H. hepaticus was not isolated from controls. The identities of the three strains at the start and end of the experiment were confirmed by PCR (Fig. 1). H. hepaticus colonization was detected in 36 of 37 infected mice via PCR analysis of the cecum or cecal contents at 6 months postinfection but not from the 11 uninfected controls.
DNA from the livers of 48 mice necropsied at 6 months was tested
for
H. hepaticus cdtB by real-time quantitative PCR (Fig.
2)
(
5). Serial dilutions of
H. hepaticus DNA from 2 fg to 2 ng
served as the positive control.
H. hepaticus 3B1 ranking and
median copy numbers for the male A/JCr mouse were consistently
higher than those for the other two strains. For six of eight
composite hepatitis scores greater than or equal to 4.0, the
H. hepaticus copy numbers exceeded 1,500. The maximum copy number
measured was 23,300.
At 3 months p.i., sham-inoculated mice had no liver lesions
and male mice infected with Hh3B1 had a higher HAI in the liver
than mice infected with HhG or Hh NET (Fig.
3). Hepatic lesions
in infected females were mild and were not different between
groups (data not shown). At 6 months postinfection, mice infected
with HhG and HhNET exhibited mild hepatitis (Fig.
4a and b).
All male mice infected with
H. hepaticus ATCC 51449 (Hh3B1)
developed severe hepatitis with a high HAI (Fig.
4c). In contrast,
lymphoid mononuclear cells comprised most of the portal infiltrates.
Hh3B1-infected male mice had a statistically significantly higher
HAI than sham-inoculated controls (
P < 0.01) and HhNet-infected
mice (
P < 0.05) (Fig.
5a and b). Additionally, there was
a trend towards higher scores for Hh3B1-infected mice than for
HhG-infected mice (
P = 0.07).
We have demonstrated that A/JCr mice infected with strains of
H. hepaticus (HhG and HhNET) lacking all or part of a 70-kb
genomic putative pathogenicity-associated island have less-severe
helicobacter-associated liver disease than mice infected with
the strain Hh3B1, which contains a complete HHGI1 island. While
the study clearly demonstrates that isolates of
H. hepaticus with different genomic contents differ significantly in their
potential to cause liver disease in A/JCr mice, further experiments
with isogenic mutants lacking the island will be required to
firmly prove the role of the HHGI1 island in these differences,
and attempts to construct series of such mutants are under way
in our laboratories. The most important limitation of the study
is that HhG and HhNET lack multiple genes in addition to the
HHGI1 island. However, most non-HHGI1 genes missing in one strain
are present in the respective other strain; 54 non-HHGI1 genes
are absent from both HhG and HhNET, whereas 67 genes are absent
from HhG only and 105 genes are absent from HhNET only, making
it unlikely that these genes are responsible for the observed
differences in virulence. Also, the differences between the
three strains in addition to the lack of the HHGI1 island and
T4SS components may also explain why a significant effect was
found only with strain HhNET, despite the fact that HhG is also
devoid of all T4SS components. This mouse model of chronic hepatitis
will be useful in dissecting the importance of
Helicobacter spp. PAI in host-pathogen relationships.

ACKNOWLEDGMENTS
Financial support: NIH R01CA67529, R01A159052, P01CA2673, and
T32RR07036 to J.G.F, MIT Environmental Health Sciences Core
Center grant NIEHS 5P30ES002109-25, and grants SFB621/B8 from
the Deutsche Forschungsgemeinschaft and PTJ-BIO 031U213B from
the BMBF competence center PathoGenoMik to S.S.

FOOTNOTES
* Corresponding author. Mailing address: Division of Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Avenue, 16-825C, Cambridge, MA 02139. Phone: (617) 253-1735. Fax: (617) 258-5708. E-mail:
jgfox{at}mit.edu.

Editor: D. L. Burns

REFERENCES
1 - Erdman, S. E., T. Poutahidis, M. Tomczak, A. B. Rogers, K. Cormier, B. Plank, B. H. Horwitz, and J. G. Fox. 2003. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 162:691-702.[Abstract/Free Full Text]
2 - Erdman, S. E., V. P. Rao, T. Poutahidis, M. M. Ihrig, Z. Ge, Y. Feng, M. Tomczak, A. B. Rogers, B. H. Horwitz, and J. G. Fox. 2003. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 63:6042-6050.[Abstract/Free Full Text]
3 - Fox, J. G., F. E. Dewhirst, J. G. Tully, B. J. Paster, L. Yan, N. S. Taylor, M. J. Collins, Jr., P. L. Gorelick, and J. M. Ward. 1994. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol. 32:1238-1245.[Abstract/Free Full Text]
4 - Fox, J. G., X. Li, L. Yan, R. J. Cahill, R. Hurley, R. Lewis, and J. C. Murphy. 1996. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect. Immun. 64:1548-1558.[Abstract]
5 - Ge, Z., D. A. White, M. T. Whary, and J. G. Fox. 2001. Fluorogenic PCR-based quantitative detection of a murine pathogen, Helicobacter hepaticus. J. Clin. Microbiol. 39:2598-2602.[Abstract/Free Full Text]
6 - Rogers, A. B., S. R. Boutin, M. T. Whary, N. Sundina, Z. Ge, K. Cormier, and J. G. Fox. 2004. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol. Pathol. 32:668-677.[CrossRef][Medline]
7 - Rogers, A. B., and J. G. Fox. 2004. Inflammation and cancer. I. Rodent models of infectious gastrointestinal and liver cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 286:G361-G366.
8 - Scheuer, P. J. 1991. Classification of chronic viral hepatitis: a need for reassessment. J. Hepatol. 13:372-374.[CrossRef][Medline]
9 - Shames, B., J. G. Fox, F. Dewhirst, L. Yan, Z. Shen, and N. S. Taylor. 1995. Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J. Clin. Microbiol. 33:2968-2972.[Abstract]
10 - Suerbaum, S., C. Josenhans, T. Sterzenbach, B. Drescher, P. Brandt, M. Bell, M. Droge, B. Fartmann, H. P. Fischer, Z. Ge, A. Horster, R. Holland, K. Klein, J. Konig, L. Macko, G. L. Mendz, G. Nyakatura, D. B. Schauer, Z. Shen, J. Weber, M. Frosch, and J. G. Fox. 2003. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc. Natl. Acad. Sci. USA 100:7901-7906.[Abstract/Free Full Text]
11 - Ward, J. M., J. G. Fox, M. R. Anver, D. C. Haines, C. V. George, M. J. Collins, Jr., P. L. Gorelick, K. Nagashima, M. A. Gonda, R. V. Gilden, et al. 1994. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl. Cancer Inst. 86:1222-1227.[Abstract/Free Full Text]
Infection and Immunity, December 2005, p. 8449-8452, Vol. 73, No. 12
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.12.8449-8452.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Fox, J. G., Shen, Z., Muthupalani, S., Rogers, A. R., Kirchain, S. M., Dewhirst, F. E.
(2009). Chronic Hepatitis, Hepatic Dysplasia, Fibrosis, and Biliary Hyperplasia in Hamsters Naturally Infected with a Novel Helicobacter Classified in the H. bilis Cluster. J. Clin. Microbiol.
47: 3673-3681
[Abstract]
[Full Text]
-
Sterzenbach, T., Lee, S. K., Brenneke, B., von Goetz, F., Schauer, D. B., Fox, J. G., Suerbaum, S., Josenhans, C.
(2007). Inhibitory Effect of Enterohepatic Helicobacter hepaticus on Innate Immune Responses of Mouse Intestinal Epithelial Cells. Infect. Immun.
75: 2717-2728
[Abstract]
[Full Text]
-
Kusters, J. G., van Vliet, A. H. M., Kuipers, E. J.
(2006). Pathogenesis of Helicobacter pylori Infection. Clin. Microbiol. Rev.
19: 449-490
[Abstract]
[Full Text]